DES PLAINES, Ill., Sept. 18 /PRNewswire-USNewswire/ -- The Emergency
Nurses Association (ENA) today announced the corporate sponsors for the
2008 ENA Annual Conference to be held in Minneapolis, MN, on September 25 -
This year's sponsors are sanofi-aventis U.S. and Bristol-Myers Squibb /
Sanofi Pharmaceuticals Partnership, Catholic Healthcare West, LifeSync
Corporation, The Medicines Company, Otsuka America Pharmaceuticals Inc, and
"We are so pleased that these companies have chosen to support
emergency nurses from across the country through their sponsorship of the
2008 ENA Annual Conference," said Denise King, RN, MSN, CEN, 2008
president, ENA. "Each of these companies has shown their commitment to
improved patient care through their support of this meeting. By sponsoring
the Annual Conference, each of these companies is directly contributing to
the continued improvement of emergency care."
The 2008 ENA Annual Conference will explore the conference theme,
Pathways to Discovery, with in-depth reviews of national issues facing
emergency care professionals, professional development sessions on career
and management issues and an exhibit hall featuring a plethora of suppliers
of products and services for the emergency care environment.
About the 2008 Annual Conference Sponsors
Catholic Healthcare West is a not-for-profit healthcare system with
over 40 facilities in California, Nevada and Arizona. They can be found in
the heart of the communities they serve, offering care that combines
state-of-the-art technologies with timeless values that reflect a
commitment to healing.
LifeSync Corporation is a medical device company committed to the
development of innovative products that improve clinical outcomes for
patients through the use of LifeSync(R) Wireless ECG products and
The Medicines Company is focused on advancing the treatment of critical
care patients through the delivery of innovative, cost-effective medicines
to the worldwide hospital marketplace. The Company markets Angiomax(R)
(bivalirudin) in the United States and other countries for use in patients
undergoing coronary angioplasty, a procedure to clear restricted blood flow
in arteries around the heart. The Company also has two products in
late-stage development, CleviprexTM (clevidipine butyrate) injectable
emulsion and cangrelor.
Otsuka America Pharmaceuticals Inc. is a successful, innovative,
fast-growing healthcare company that commercializes Otsuka-discovered and
other product opportunities in North America, with a strong focus on and
commitment to neuroscience, cardiology, oncology, and gastroenterology. The
Company is part of the Otsuka Pharmaceutical Group, which is comprised of
104 companies and approximately 31,000 people around the world.
Physio-Control pioneered defibrillation technology more than 50 years
ago and provides LIFEPAK(R) products for cardiac emergencies in hospital
For more information about the 2008 ENA Annual Conference, visit the
ENA website at www.ena.org.
About the Emergency Nurses Association
The Emergency Nurses Association (ENA) is the only professional nursing
association dedicated to defining the future of emergency nursing and
emergency care through advocacy, expertise, innovation, and leadership.
Founded in 1970, ENA serves as the voice of more than 35,000 members and
their patients through research, publications, professional development,
injury prevention, and patient education. Additional information is
available at ENA's Web site, at www.ena.org.
SOURCE Emergency Nurses Association